-
1.
公开(公告)号:US20220370354A1
公开(公告)日:2022-11-24
申请号:US17608691
申请日:2020-05-08
Applicant: ModernaTX, Inc.
Inventor: Tal Zaks , Kelly Lindert , Lin Tung Guey
IPC: A61K9/127 , A61K31/7115 , A61K9/00 , A61K9/51 , A61P3/00
Abstract: This disclosure relates to mRNA therapy for the treatment of methylmalonic acidemia (MMA). mRNAs for use in the invention, when administered in vivo, encode methylmalonyl-CoA mutase (MUT). mRNA therapies of the disclosure increase and/or restore deficient levels of MUT expression and/or activity in subjects.